- Home
- ECOR vs VRCA Comparison
ECOR vs VRCA Comparison
Compare ECOR & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- VRCA
- Stock Information
- Founded
- ECOR 2005
- VRCA 2013
- Country
- ECOR United States
- VRCA United States
- Employees
- ECOR N/A
- VRCA N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- ECOR Health Care
- VRCA Health Care
- Exchange
- ECOR Nasdaq
- VRCA Nasdaq
- Market Cap
- ECOR 40.0M
- VRCA 40.6M
- IPO Year
- ECOR 2018
- VRCA 2018
- Fundamental
- Price
- ECOR $5.09
- VRCA $4.23
- Analyst Decision
- ECOR Strong Buy
- VRCA Buy
- Analyst Count
- ECOR 2
- VRCA 4
- Target Price
- ECOR $25.50
- VRCA $60.00
- AVG Volume (30 Days)
- ECOR 46.6K
- VRCA 602.4K
- Earning Date
- ECOR 11-12-2025
- VRCA 11-03-2025
- Dividend Yield
- ECOR N/A
- VRCA N/A
- EPS Growth
- ECOR N/A
- VRCA N/A
- EPS
- ECOR N/A
- VRCA N/A
- Revenue
- ECOR $27,700,000.00
- VRCA $14,704,000.00
- Revenue This Year
- ECOR $24.48
- VRCA $332.45
- Revenue Next Year
- ECOR $44.35
- VRCA $12.85
- P/E Ratio
- ECOR N/A
- VRCA N/A
- Revenue Growth
- ECOR 30.16
- VRCA 5.72
- 52 Week Low
- ECOR $4.16
- VRCA $3.82
- 52 Week High
- ECOR $19.49
- VRCA $17.38
- Technical
- Relative Strength Index (RSI)
- ECOR 48.99
- VRCA 43.23
- Support Level
- ECOR $4.80
- VRCA $3.95
- Resistance Level
- ECOR $5.26
- VRCA $4.85
- Average True Range (ATR)
- ECOR 0.25
- VRCA 0.29
- MACD
- ECOR 0.03
- VRCA -0.00
- Stochastic Oscillator
- ECOR 55.17
- VRCA 32.62
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.